Navigation Links
Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
Date:11/7/2008

inical trials of

patients with cancer. A rate of hemoglobin rise of 1 g/dL over 2 weeks

may contribute to these risks.

-- Dose of PROCRIT

-- Chronic renal failure patients: The dose of PROCRIT should be titrated for each patient to achieve and maintain hemoglobin levels between 10 to 12 g/dL. If a patient does not attain hemoglobin levels of 10 to 12 g/dL despite 12 weeks of appropriate PROCRIT therapy, see DOSAGE and ADMINISTRATION in the PROCRIT Prescribing Information.

-- Cancer patients: PROCRIT therapy should not be initiated at hemoglobin levels greater than or equal to 10 g/dL. The dose of PROCRIT should be titrated for each patient to achieve and maintain the lowest hemoglobin level sufficient to avoid the need for blood transfusion. Discontinue if after 8 weeks of therapy there is no response as measured by hemoglobin levels or if transfusions are still required (see recommended Dose Modification section in DOSAGE and ADMINISTRATION of the PROCRIT Prescribing Information).

-- HIV patients: The dose of PROCRIT should be titrated for each patient to achieve and maintain the lowest hemoglobin level sufficient to avoid transfusion and not to exceed the upper safety limit of 12 g/dL.

-- Monitor hemoglobin regularly during therapy, weekly until hemoglobin

becomes stable.

-- Cases of pure red cell aplasia (PRCA) and of severe anemia, with or

without other cytopenias, associated with neutralizing antibodies to

erythropoietin have been reported in patients treated with PROCRIT;

predominantly in patients with chronic renal failure receiving PROCRIT

by subcutaneous administration. If any patient develops a sudden loss

of response to PROCRIT, accompanied by severe anemia and low

reticulocyte count, and anti-erythropoietin antibody-associated anemia

is suspected, withhold PROCRIT and other erythropoietic proteins.


'/>"/>

SOURCE Ortho Biotech Products, L.P.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
2. A Worldwide Phase III Clinical Trial Seeks U.S. Patients to Explore Investigational Drug Phenoxodiol
3. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
4. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
5. Replidynes Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile
6. Replidynes Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile
7. Wyeth Presents Phase 3 Fracture Data for Bazedoxifene, an Investigational Therapy for Osteoporosis
8. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
9. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
10. Lexicon Reports Initial Clinical Trial Results for LX1031, an Investigational New Drug for Irritable Bowel Syndrome
11. Roches Investigational Polymerase Inhibitor, Combined with PEGASYS(R) and COPEGUS(TM), Shows Potent Antiviral Activity in Treatment of Chronic Hepatitis C at Four Weeks
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... -- MedAptus® today announced the launch of Assign, the ... for busy inpatient provider teams. Assign was developed ... hospitalists or other rounding providers based on needs ... as ensuring patient safety, proper reimbursement and overall ... In an increasingly risk-based healthcare market, ...
(Date:3/30/2015)... N.C. , March 30, 2015  Edison ... announced a worldwide search for product innovations to ... most promising ideas uncovered during the 8-week search ... for potential commercialization.  Invention ideas can be submitted ... now through May 28, 2015. ...
(Date:3/30/2015)... 30, 2015 Nutrastar International Inc. (OTCQB: NUIN) ... of premium branded consumer products, including commercially cultivated Cordyceps ... foods, today announced its results for the full year ... for the Full Year Ended December 31, 2014 ... as compared to $43.35 million in full year 2013. ...
Breaking Medicine Technology:MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 2MedAptus Launches Automated Patient Assignment Solution for Hospitalists, Other Rounding Specialists 3Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 2Edison Nation Medical Announces Open Innovation Search Focused on Senior Mobility Products 3Nutrastar International, Inc. Announces Full Year 2014 Results 2Nutrastar International, Inc. Announces Full Year 2014 Results 3Nutrastar International, Inc. Announces Full Year 2014 Results 4Nutrastar International, Inc. Announces Full Year 2014 Results 5Nutrastar International, Inc. Announces Full Year 2014 Results 6Nutrastar International, Inc. Announces Full Year 2014 Results 7Nutrastar International, Inc. Announces Full Year 2014 Results 8Nutrastar International, Inc. Announces Full Year 2014 Results 9
... 2, 2007-The U.S. Food and Drug,Administration (FDA) today ... existing black box warning on,their products' labeling to ... behavior, known as suicidality, in young,adults ages 18 ... to two months). , The proposed labeling changes ...
... FDA notified,healthcare professionals of important new safety ... recent,clinical study in patients with limited-stage small ... phase,II clinical trial study combined chemotherapy and ... serious adverse events of TE,fistula (one fatal) ...
Cached Medicine Technology:FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 2FDA Proposes New Warnings About Suicidal Thinking, Behavior in,Young Adults Who Take Antidepressant Medications 3
(Date:3/30/2015)... (PRWEB) March 30, 2015 The pharmaceutical ... and flexible biological manufacturing plants. This is primarily due ... business. , This has forced facilities to produce and ... The existing facilities have been forced to expand production, ... change of ownership. , Most of these facilities have ...
(Date:3/30/2015)... GoHooper.com announces new website for Grace Pediatrics. Grace ... infants, children and adolescents and partners with parents to ... owner/provider Mark Hughes, MD, FAAP and a his team ... in the extensive range of pediatric care from newborn ... who meet the medical field's highest standards, and who ...
(Date:3/30/2015)... Marcos, CA (PRWEB) March 30, 2015 Dr. ... California, offers no cost 15 minute second opinion consultations ... work. , “The statistics on dental second opinions show ... second opinion on major dental works. Only 6%” – says ... a second opinion even when fully trusting the dental care ...
(Date:3/30/2015)... Southern Med Law, a law firm representing ... filed a Mirena IUD lawsuit on behalf ... premature birth in 2012. The complaint, which is currently ... Mirena IUD failed to prevent pregnancy due to problems ... to remove. The inability to remove the IUD from ...
(Date:3/30/2015)... iCareTech ” was featured on NewsWatch as part of its ... and coolest technology products and services available to consumers. Scott ... review and shared with viewers how this is the very ... fields. , Wearable technology has been one of the most ... Well, at CES, NewsWatch TV came across the first medical ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 2Health News:FDAnews Announces: Aging Aseptic and Biological Manufacturing Facilities: Design and Renovation for Compliance Webinar, April 16, 2015 3Health News:Nashville Web Design Company Announces New Site Launch For Pediatrics Doctor 2Health News:Allred Dental Offers Complimentary 15 Minute Consults with Dr. Jeffrey Allred in San Marcos, CA 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 2Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 3Health News:Mirena Lawsuit Filed By Southern Med Law Seeks Compensation For Purported Wrongful Death Following Premature Birth Of Infant 4Health News:World’s First Medical Intelligent Band was Featured on NewsWatch Television on January 30, 2015 2
... NEW YORK, July 21 BET News correspondent, Andre Showell will lead ... in Washington on Wednesday, July 22 ( ) at ... re-air an encore broadcast of the entire news conference along with pre ... 10:00 p.m. The President is expected to discuss health ...
... , ST. LOUIS, July 21 Young Innovations, Inc. ... quarter and for the first six-months ended June 30, 2009. , ... were $24.6 million, a decrease of 4.9% over the $25.9 million reported ... $5.4 million from $5.2 million in the prior year. Net income for ...
... , , , , ... SMA ), a leading independent provider of products to the global orthopaedic ... second quarter 2009 financial results for the period ending July 4, 2009 ... host an accompanying conference call at 8:00 a.m. ET on Thursday, August ...
... July 21 / PRNewswire / -- Spheris, a leading global ... release of its financial results for the second quarter ended June 30, ... issue its earnings release for the second quarter of 2009 after the ... a conference call on Friday, August 7, 2009, at 8 a.m. CT. ...
... , , OAKLAND, ... provide care at hospitals owned by Tenet Healthcare Corporation organized ... access to sick leave. , , ... Nurses Organizing Committee/California Nurses Association (NNOC/CNA) and Service Employees International ...
... , , , , ... VRX ) today announced that it will host a conference call ... August 4, 2009 at 10:00 a.m. EDT (7:00 a.m. PDT) to discuss ... The dial-in number to participate on this call is (877) 295-5743, ...
Cached Medicine News:Health News:BET Networks Airs Special Coverage of President Obama's News Conference on Health Care 2Health News:Young Innovations, Inc. Announces Record Earnings for the Quarter and Six-Months Ended June 30, 2009 2Health News:Young Innovations, Inc. Announces Record Earnings for the Quarter and Six-Months Ended June 30, 2009 3Health News:Young Innovations, Inc. Announces Record Earnings for the Quarter and Six-Months Ended June 30, 2009 4Health News:Young Innovations, Inc. Announces Record Earnings for the Quarter and Six-Months Ended June 30, 2009 5Health News:Young Innovations, Inc. Announces Record Earnings for the Quarter and Six-Months Ended June 30, 2009 6Health News:Symmetry Medical to Report Second Quarter 2009 Financial Results on August 6, 2009 2Health News:Spheris Sets Second Quarter 2009 Earnings Release and Conference Call Dates 2Health News:Tenet Nurses, Healthcare Workers Take Action to Protest Sick Leave Cuts 2Health News:Valeant Pharmaceuticals to Announce 2009 Second Quarter Results on August 4, 2009 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: